168 related articles for article (PubMed ID: 18523752)
1. Prognostic value of midregional pro-atrial natriuretic peptide in ventilator-associated pneumonia.
Seligman R; Papassotiriou J; Morgenthaler NG; Meisner M; Teixeira PJ
Intensive Care Med; 2008 Nov; 34(11):2084-91. PubMed ID: 18523752
[TBL] [Abstract][Full Text] [Related]
2. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia.
Seligman R; Seligman BG; Teixeira PJ
J Bras Pneumol; 2011; 37(4):495-503. PubMed ID: 21881740
[TBL] [Abstract][Full Text] [Related]
3. Midregional pro-atrial natriuretic peptide and procalcitonin improve survival prediction in VAP.
Boeck L; Eggimann P; Smyrnios N; Pargger H; Thakkar N; Siegemund M; Marsch S; Rakic J; Tamm M; Stolz D
Eur Respir J; 2011 Mar; 37(3):595-603. PubMed ID: 20530040
[TBL] [Abstract][Full Text] [Related]
4. Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.
Masiá M; Papassotiriou J; Morgenthaler NG; Hernández I; Shum C; Gutiérrez F
Clin Chem; 2007 Dec; 53(12):2193-201. PubMed ID: 17951293
[TBL] [Abstract][Full Text] [Related]
5. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
6. Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD.
Bernasconi M; Tamm M; Bingisser R; Miedinger D; Leuppi J; Müller B; Christ-Crain M; Stolz D
Chest; 2011 Jul; 140(1):91-99. PubMed ID: 21106656
[TBL] [Abstract][Full Text] [Related]
7. MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.
Vazquez M; Jockers K; Christ-Crain M; Zimmerli W; Müller B; Schuetz P
Int J Cardiol; 2012 Apr; 156(1):16-23. PubMed ID: 21093937
[TBL] [Abstract][Full Text] [Related]
8. Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.
Krüger S; Papassotiriou J; Marre R; Richter K; Schumann C; von Baum H; Morgenthaler NG; Suttorp N; Welte T;
Intensive Care Med; 2007 Dec; 33(12):2069-78. PubMed ID: 17938883
[TBL] [Abstract][Full Text] [Related]
9. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
[TBL] [Abstract][Full Text] [Related]
11. Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia.
Seligman R; Papassotiriou J; Morgenthaler NG; Meisner M; Teixeira PJ
Crit Care; 2008; 12(1):R11. PubMed ID: 18252006
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
[TBL] [Abstract][Full Text] [Related]
13. Proatrial natriuretic peptide is a better predictor of 28-day mortality in septic shock patients than proendothelin-1.
Guignant C; Venet F; Voirin N; Poitevin F; Malcus C; Bohé J; Lepape A; Monneret G
Clin Chem Lab Med; 2010 Dec; 48(12):1813-20. PubMed ID: 20704539
[TBL] [Abstract][Full Text] [Related]
14. Mid-regional pro-atrial natriuretic peptide independently predicts short-term mortality in COVID-19.
Kaufmann CC; Ahmed A; Kassem M; Freynhofer MK; Jäger B; Aicher G; Equiluz-Bruck S; Spiel AO; Funk GC; Gschwantler M; Fasching P; Wojta J; Huber K
Eur J Clin Invest; 2021 May; 51(5):e13531. PubMed ID: 33657664
[TBL] [Abstract][Full Text] [Related]
15. Midregional pro-A-type natriuretic peptide for diagnosis and prognosis in patients with suspected acute myocardial infarction.
Meune C; Twerenbold R; Drexler B; Balmelli C; Wolf C; Haaf P; Reichlin T; Irfan A; Reiter M; Zellweger C; Meissner J; Stelzig C; Freese M; Capodarve I; Mueller C
Am J Cardiol; 2012 Apr; 109(8):1117-23. PubMed ID: 22257708
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke.
Fischer M; Katan M; Morgenthaler NG; Seiler M; Müller B; Lackner P; Errath M; Helbok R; Pfausler B; Beer R; Schmutzhard E; Broessner G
Cerebrovasc Dis; 2014; 37(2):128-33. PubMed ID: 24481415
[TBL] [Abstract][Full Text] [Related]
17. Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia.
Prat C; Lacoma A; Dominguez J; Papassotiriou J; Morgenthaler NG; Andreo F; Tudela P; Ruiz-Manzano J; Ausina V
J Infect; 2007 Nov; 55(5):400-7. PubMed ID: 17825918
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.
Brueckmann M; Huhle G; Lang S; Haase KK; Bertsch T; Weiss C; Kaden JJ; Putensen C; Borggrefe M; Hoffmann U
Circulation; 2005 Jul; 112(4):527-34. PubMed ID: 16027260
[TBL] [Abstract][Full Text] [Related]
20. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
